Basic Information
ID: ALA4136401
Type: Functional
Description: Antiviral activity against HIV1 3B harboring reverse transcriptase F227L/V106A double mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by MTT assay
Format: BAO_0000218
Organism: Human immunodeficiency virus 1
Strain: 3B
Target: Human immunodeficiency virus 1(ALA378)
Document: ALA4130567
Antiviral activity against HIV1 3B harboring reverse transcriptase F227L/V106A double mutant infected in human MT4 cells assessed as inhibition of virus-induced cytopathic effect after 5 days by MTT assay: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4136401
EC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 267.24 | -0.20 | -0.20 |
| 435.29 | 4.72 | 4.72 |
| 590.73 | 5.63 | 5.63 |
| 522.63 | 6.00 | 6.00 |
| 612.58 | 6.44 | 6.44 |
| 576.52 | 6.89 | 6.89 |
| 601.68 | 6.69 | 6.69 |
| 551.67 | 5.81 | 5.81 |
| 497.62 | 6.13 | 6.13 |
| 565.62 | 7.14 | 7.14 |
| 558.69 | 5.55 | 5.55 |
| 515.61 | 6.26 | 6.26 |